Spontaneous reporting-of what? Clinical concerns about drugs

Adverse reactions to oncologic drugs: spontaneous reporting and signal detection.

Oncology is one of the areas of medicine with the most active research being conducted on new drugs. New pharmacological entities frequently enter the clinical arena, and therefore, the safety profile of anticancer products deserves continuous monitoring. However, only very severe and (unusual) suspected adverse drug reactions (ADRs) are usually reported, since cancer patients develop ADRs very...

What Concerns Do Biometrics Raise and How Do They Differ from Concerns about Other Identification Methods?

Others, however, deliberately choose not to participate in biometric programs because of their individual beliefs. While these individuals constitute a relatively small minority, they are the most likely contingent to voice their concerns. Their criticism will probably not cause a biometric program to collapse or render it ineffective. However, such criticism could inhibit a biometric program’s...

What Market Risk Capital Reporting Tells Us about Bank Risk

n recent years, financial market supervisors and the financial services industry have placed increased emphasis on the role of public disclosure in ensuring the efficient and prudent operation of financial institutions. In particular, disclosures about financial institutions’ risk exposures have frequently been cited as an important way for debt and equity market participants to get the informa...

Clinical Concerns about Recurrence of Non-Functioning Pituitary Adenoma

BACKGROUND Non-functioning pituitary adenomas (NFPA) are clinically challenging because they present at a late stage with local mass effects or hypopituitarism. Surgery for non-functioning pituitary adenoma requires a special strategic approach for both minimal morbidity and radical resection. However, the clinical predictive factors associated with recurrence are limited. Here, we investigated...

New reporting system for potential safety concerns of drugs on the market.